SOURCE: Progressive Care Inc.
MIAMI, FL--(Marketwire - Sep 20, 2012) - Progressive Care Inc. (OTCBB: RXMD), and its wholly-owned subsidiary PharmCo, LLC (collectively, "Progressive Care"), a provider of prescription pharmaceuticals, specializing in anti-retroviral patient management, long-term care and durable medical equipment, announced today that it has retained Consulting for Strategic Growth 1 ("CFSG1") as its U.S. investor and public relations representative. Stanley Wunderlich, Chairman and Chief Executive Officer of CFSG1, and his team of experts will begin to implement an investor and public relations program focused on investor awareness related to Progressive Care as it continues to expand its facilities, acquire additional operating pharmacies and further its current business lines.
Mr. Wunderlich remarked, "We are extremely pleased to have been chosen by Progressive Care to become their agency of record. Over the years, Progressive Care has become one of the premier pharmacies in the South Florida area, specializing in the management and care of special needs patients. CFSG1 is excited to introduce this Company to our wide-ranging network in the investment community and financial media."
About Progressive Care Inc.
Progressive Care (RXMD) and its subsidiary PharmCo, LLC, a provider of prescription pharmaceuticals, specialize in anti-retroviral patient care, long term care and durable medical equipment. Our operations are currently focused on the South Florida market, where management believes demographics are synergistic with its marketing efforts of anti-retroviral patient management and its DME product line. Progressive Care is devoted to improving the quality of life of special needs patients through increasing access to vital medication and equipment, raising awareness, and providing education and other services to local communities and long term care institutions. For more information regarding RXMD, please visit http://www.progressivecareus.com, or view our reports and filings with the U.S. Securities and Exchange Commission on http://www.sec.gov.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.